Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPérez Fidalgo, José A
dc.contributor.authorOrtega, Eugenia
dc.contributor.authorPonce Sebastia, Jordi
dc.contributor.authorRedondo Sanchez, Andres
dc.contributor.authorSevilla, Isabel
dc.contributor.authorValverde Morales, Claudia Maria
dc.date.accessioned2023-04-26T09:38:40Z
dc.date.available2023-04-26T09:38:40Z
dc.date.issued2023-03-28
dc.identifier.citationPérez-Fidalgo JA, Ortega E, Ponce J, Redondo A, Sevilla I, Valverde C, et al. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Ther Adv Med Oncol. 2023 Mar 28;15:1–19.
dc.identifier.issn1758-8359
dc.identifier.urihttps://hdl.handle.net/11351/9423
dc.descriptionAdenosarcoma; Guidelines; Uterine sarcoma
dc.description.abstractUterine sarcomas are very infrequent and heterogeneous entities. Due to its rarity, pathological diagnosis, surgical management, and systemic treatment are challenging. Treatment decision process in these tumors should be taken in a multidisciplinary tumor board. Available evidence is low and, in many cases, based on case series or clinical trials in which these tumors have been included with other soft tissue sarcoma. In these guidelines, we have tried to summarize the most relevant evidence in the diagnosis, staging, pathological disparities, surgical management, systemic treatment, and follow-up of uterine sarcomas.
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesTherapeutic Advances in Medical Oncology;15
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectÚter - Càncer - Diagnòstic
dc.subjectÚter - Tumors - Diagnòstic
dc.subject.meshSarcoma, Endometrial Stromal
dc.subject.meshUterine Neoplasms
dc.subject.mesh/diagnosis
dc.titleUterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1177/17588359231157645
dc.subject.decssarcoma del estroma endometrial
dc.subject.decsneoplasias uterinas
dc.subject.decs/diagnóstico
dc.relation.publishversionhttps://doi.org/10.1177/17588359231157645
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Pérez-Fidalgo JA] Oncology and Hematology Department, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario, CIBERONC Spain, Valencia, Spain. [Ortega E] Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [Ponce J] Gynecology Department, Hospital Universitario de Bellvitge. IDIBELL. Universidad de Barcelona, Barcelona, Spain. [Redondo A] Medical Oncology Department, Hospital Universitario La PazIdiPAZ, Madrid, Spain. [Sevilla I] Clinical and Translational Research in Cancer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional and Virgen de la Victoria de Málaga, Málaga, Spain. [Valverde C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid37007636
dc.identifier.wos000959665900001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record